Defects of Adrenal Steroidogenesis

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 1897-1920

  Wajnrajch, Michael P ^a,b   New, Maria I ^c  

^a PFIZER INC   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85063962590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00103-9     Document Type: Chapter

References (250)

1. MI New, PC White, S Pang, et al. (1989) The adrenal hyperplasias. CR Scriver, et al., (Eds) The Metabolic Basis of Inherited Disease New York: McGraw-Hill 1881-1917.
2. MM Grumbach and FA Conte (1992) Disorders of sex differentiation. JD Wilson, DW Foster,(Eds) Williams’ Textbook of Endocrinology Philadelphia: WB Saunders 853-951.
3. J Gabrilove, D Sharma and R Dorfman (1965) Adrenocortical 11B-hydroxylase deficiency and virilism first manifest in the adult woman. N Engl J Med 272 1189-1194.
4. D Newmark, R Dluhy, G Williams, et al. (1977) Partial 11-hydroxylase and 21-hydroxylase deficiencies in hirsute women. Am J Obstet Gynecol 127 594-598.
5. G Cathelineau, J Brerault and W Fiet (1980) Adrenocortical 11β-hydroxylation defect in adult women with postmenarchal onset of symptoms. J Clin Endocrinol Metab 51 287-291.
6. M Birnbaum and L Rose (1984) Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet Gynecol 63 445-451.
7. A Hurwitz, C Brautbar and A Milwidsky (1985) Combined 21- and 11β-hydroxylase deficiency in familial congenital adrenal hyperplasia. J Clin Endocrinol Metab 60 631-638.
8. PA Clark (2000) Nonclassic 11-beta-hydroxylase deficiency: report of two patients and review. J Pediatr Endocr Metab 13 105-109.
9. L De Crecchio (1865) Sopra un caso di apparenze virile in una donna. Morgagni 7 1951.
10. J Fibiger (1905) Beiträge zur Kenntnis des weiblichen Scheinzwittertums. Virchows Arch Pathol Anat 181 1-51.
11. A Apert (1910) Dystrophies en relation avec des lésions de capsules surrénales. Hirsutisme et progeria. Bull Soc Pediatr (Paris) 12 501-518.
12. CJ Migeon (1989) Diagnosis and treatment of adrenogenital disorders. L DeGroot, et al., (Eds) Endocrinology Philadelphia: WB Saunders 1676-1704.
13. L Wilkins (1965) Adrenal cortex: virilizing adrenal hyperplasia; virilizing and feminizing tumors; and primary hyperaldosteronism. L Wilkins,(Eds) The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence Springfield, IL: Charles C Thomas 368-381.
14. AM Bongiovanni (1953) Detection of pregnanediol and pregnanetriol in urine of patients with adrenal hyperplasia: suppression with cortisone: a preliminary report. Bull Johns Hopkins Hosp 92 244-251.
15. AM Bongiovanni and AW Root (1963) The adrenogenital syndrome. N Engl J Med 268 1283-1289. 1342–1351, 1391–1399
16. WR Eberlein and AM Bongiovanni (1955) Congenital adrenal hyperplasia with hypertension: unusual steroid pattern in blood and urine. J Clin Endocrinol Metab 15 1531-1534.
17. A Prader and RE Siebenmann (1957) Nebenniereninsuffizienz bei kongenitaler Lipoid-hyperplasie der Nebennieren. Helv Paediatr Acta 12 569-595.
18. EG Biglieri, MA Herron and N Brust (1966) 17-Hydroxylation deficiency in man. J Clin Invest 45 1946-1954.
19. MI New (1970) Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest 49 1930-1941.
20. B Dupont, SE Oberfield, EM Smithwick, et al. (1977) Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet 2 1309-1312.
21. PC White, MI New and B Dupont (1984) HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A 81 7505-7509.
22. D Lin, T Sugawara, JF Strauss, et al. (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267 1828-1831.
23. S Suwa, K Shimozawa, T Kitagawa, et al. (1987) Collaborative study on regional neonatal screening for congenital adrenal hyperplasia in Japan. BLJ Therell,(Eds) Advances in Neonatal Screening New York: Elsevier 279-286.
24. AM Wallace, GH Beastall, R Kennedy, et al. (1987) Congenital adrenal hyperplasia screening in 120,000 Scottish neonates. BLJ Therell,(Eds) Advances in Neonatal Screening New York: Elsevier 293-295.
25. J Sólyom and IA Hughes (1989) Value of selective screening for congenital adrenal hyperplasia in Hungary. Arch Dis Child 64 338-342.
26. SY Pang, MA Wallace, L Hofman, et al. (1988) Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81 866-874.
27. WS Cutfield and D Webster (1995) Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 126 118-121.
28. E Cacciari, A Balsamo, et al. (1983) Neonatal screening for congenital adrenal hyperplasia. Arch Dis Child 58 803-806.
29. WS Cutfield and D Webster (1995) Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 126 118-121.
30. DB Allen, GL Hoffman, P Fitzpatrick, et al. (1997) Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 130 128-133.
31. N Janejai, P Krasao, et al. (2003) Congenital adrenal hyperplasia: should nationwide screening be implemented in Thailand? Southeast Asian J Trop Med Public Health 34(suppl 3), 170-173.
32. PW Speiser, B Dupont, P Rubinstein, et al. (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Genet 37 650-667.
33. SL Sherman, CE Aston, NE Morton, et al. (1988) A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. Am J Hum Genet 42 830-838.
34. M Dumic, L Brkljacic, P Speiser, et al. (1990) An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population. Acta Endocrinol (Copenh) 122 703-710.
35. B Bonne-Tamir, JG Bodmer, WF Bodmer, et al. (1978) HLA polymorphism in Israel: an overall comparative analysis. Tissue Antigens 11 235-250.
36. KK Kidd, JR Kidd, B Bonne-Tamir, et al. (1992) Nuclear DNA polymorphisms and population relationships. B Bonne-Tamir, A Adam,(Eds) Genetic Diversity among Jews. Diseases and Markers at the DNA Level London: Oxford University Press 33-44.
37. N Josso (1986) Antimullerian hormone: new perspectives for a sexist molecule. Endocr Rev 7 421-433.
38. G Klingensmith, S Garcia, H Jones, et al. (1977) Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 90 996-1004.
39. J DiMartino-Nardi, E Stoner, A O’Connell, et al. (1986) The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). R Illig, HKA Visser,(Eds) Paediatric Endocrinology Copenhagen: Acta Endocrinologica Copenhagen 305-314.
40. MI New, JM Gertner, PW Speiser, et al. (1988) Growth and final height in classical and nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn 30 79-88.
41. MG Vogiatzi, K Lin-Su and MI New (2003) Treatment with growth hormone and GnRH analogue improves final height in children with congenital adrenal hyperplasia. Endocrine Society 2003 Philadelphia: The Endocrine Society
42. MR Sciannamblo, D Cuccato, G Chiumello, et al. (2006) Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 91 4453-4458.
43. H Falhammar, H Filipsson, et al. (2007) Fractures and Bone Mineral Density in Adult Women with 21-Hydroxylase Deficiency. J Clin Endocrinol Metab 92 4643-4649.
44. RB Barnes, RL Rosenfeld, DA Ehrmann, et al. (1994) Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 79 1328-1333.
45. R Lobo and U Goebelsmann (1980) Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol 138 720-726.
46. HFL Meyer-Bahlburg (1999) What causes low rates of child-bearing in congenital adrenal hyperplasia? J Clin Endocrinol Metab 84 1844-1847.
47. L Trinh, S Nimkarn, et al. (2007) Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 20 883-891.
48. A Prader (1958) Vollkommen männliche äussere Genitalentwicklung und Salzverlustsyndrom bei Madchen mit kongenitalem Adrenogenitalem Syndrom. Helv Paediatr Acta 13 5-14.
49. NM Stikkelbroeck, BJ Otten, A Pasic, et al. (2001) High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86 5721-5728.
50. M Cabrera, M Vogiatzi and M New (2001) Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 86 3070-3080.
51. R Ravichandran, F Lafferty, MJ McGinniss, et al. (1996) Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 81 1776-1779.
52. F Beuschlein, E Schulze, P Mora, et al. (1998) Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. J Clin Endocrinol Metab 83 2585-2588.
53. DP Merke, GP Chrousos, G Eisenhofer, et al. (2000) Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 343 1362-1368.
54. M Tusie-Luna, P Traktman and PC White (1990) Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem 265 20916-20922.
55. SH Chiou, MC Hu and BC Chung (1990) A missense mutation at Ile172-Asn or Arg356-Trp causes steroid 21-hydroxylase deficiency. J Biol Chem 265 3549-3552.
56. JM Horner, RL Hintz and JA Luetscher (1979) The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 48 776-783.
57. E Stoner, J Dimartino-Nardi, U Kuhnle, et al. (1986) Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clin Endocrinol (Oxf) 24 9-20.
58. Y Morel, M David, MG Forest, et al. (1989) Gene conversions and rearrangements cause discordance between inheritance of forms of 21-hydroxylase deficiency and HLA types. J Clin Endocrinol Metab 68 592-599.
59. PW Speiser, L Agdere, H Ueshiba, et al. (1991) Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. N Engl J Med 324 145-149.
60. B Dupont, M Pollack, L Levine, et al. (1981) Congenital adrenal hyperplasia and HLA: joint report from the Eighth International Histocompatibility Workshop. P Terasaki,(Eds) Histocompatibility Testing 1980 Los Angeles: UCLA Tissue Typing Laboratory 693-706.
61. J Trowsdale, J Ragoussis, RD Campbell, et al. (1991) Map of the human MHC. Immunol Today 12 443-446.
62. B Dupont, R Virdis, AJ Lerner, et al. (1984) Distinct HLA-B antigen associations for the salt-wasting and simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. ED Albert, M Baur, W Mayr,(Eds) Histocompatibility Testing 1984 Heidelberg: Springer-Verlag 660.
63. LS Levine, B Dupont, F Lorenzen, et al. (1980) Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 51 1316-1324.
64. B Kohn, LS Levine, MS Pollack, et al. (1982) Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55 817-827.
65. JW Temeck, SY Pang, C Nelson, et al. (1987) Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab 64 609-617.
66. A Granoff, F Chasalow and S Blethen (1985) 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. J Clin Endocrinol Metab 60 409-415.
67. A Lucky, R Rosenfield, J McGuire, et al. (1986) Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 62 840-848.
68. L Rose, S Newmark, J Strauss, et al. (1976) Adrenocortical hydroxylase deficiencies in acne vulgaris. J Invest Dermatol 66 324-326.
69. SY Pang, AJ Lerner, E Stoner, et al. (1985) Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J Clin Endocrinol Metab 60 428-439.
70. D Child, D Bullock and D Anderson (1980) Adrenal steroidogenesis in hirsute women. Clin Endocrinol (Oxf) 12 595-601.
71. M Gibson, R Lackritz, I Schiff, et al. (1980) Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women. Fertil Steril 33 43-48.
72. G Chrousos, D Loriaux, D Mann, et al. (1982) Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 96 143-148.
73. ES Knochenhauer, C Cortet-Rudelli, RD Cunningham, et al. (1997) Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 82 479-485.
74. D Riddick and C Hammond (1975) Adrenal virilism due to 21-hydroxylase deficiency in the postmenarchial female. Obstet Gynecol 45 21-24.
75. M Birnbaum and L Rose (1979) The partial adrenocortical hydroxylase deficiency syndrome in infertile women. Fertil Steril 32 536-541.
76. GP Chrousos, DL Loriaux, RJ Sherines, et al. (1981) Bilateral testicular enlargement resulting from inapparent 21-hydroxylase deficiency. J Urol 126 127-128.
77. PC White, D Grossberger, BJ Onufer, et al. (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A 82 1089-1093.
78. MC Carroll, RD Campbell and RR Porter (1985) Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A 82 521-525.
79. PC White, MI New and B Dupont (1986) Structure of the human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A 83 5111-5115.
80. Y Higashi, H Yoshioka, et al. (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A 83 2841-2845.
81. F Harada, A Kimura, et al. (1987) Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. Proc Natl Acad Sci U S A 84 8091-8094.
82. M Amor, KL Parker, et al. (1988) Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A 85 1600-1607.
83. PW Speiser, MI New and PC White (1988) Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. N Engl J Med 319 19-23.
84. RO Rocha, AE Billerbeck, et al. (2008) The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androgen receptor gene. Clin Endocrinol (Oxf) 68 226-232.
85. AM Bongiovanni, WR Eberlein, AS Goldman, et al. (1967) Disorders of adrenal steroid biogenesis. Recent Prog Horm Res 23 375-449.
86. M Zerah, SY Pang and MI New (1987) Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 65 227-232.
87. S Pang, J Hotchkiss, AL Drash, et al. (1977) Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45 1003-1008.
88. BL Therrell Jr, SA Berenbaum, et al. (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101(4), 583-590.
89. P Cavarzere, M Camilot, et al. (2005) Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program. Horm Res 63 180-186.
90. L Gruñieiro-Papendieck, A Chiesa, et al. (2008) Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina. J Pediatr Endocrinol Metab 21 73-78.
91. LS Levine, W Rauh, K Gottesdiener, et al. (1980) New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 50 258-263.
92. S Chua, P Szabo, A Vitek, et al. (1987) Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 84 7193-7197.
93. E Mornet, J Dupont, A Vitek, et al. (1989) Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem 264 20961-20967.
94. SE Taymans, S Pack, E Pak, et al. (1998) Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J Clin Endocrinol Metab 83 1033-1036.
95. A Rösler and E Leiberman (1984) Enzymatic defects of steroidogenesis: 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. MI New, LS Levine,(Eds) Adrenal Diseases in Childhood: Pathophysiologic and Clinical Aspects Basel: S. Karger 47-71.
96. A Rösler, E Leiberman and J Sack (1982) Clinical variability of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Horm Res 16 133-141.
97. S Pang, LS Levine, F Lorenzen, et al. (1980) Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 50 586-589.
98. PC White, KM Curnow and L Pascoe (1994) Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev 15 421-438.
99. MI New and MP Seaman (1970) Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 30 361-371.
100. HM Gandy, EH Keutmann and AJ Izzo (1960) Characterization of urinary steroids in adrenal hyperplasia: isolation of metabolites of cortisol, compound S, and deoxycorticosterone from a normotensive patient with adrenogenital syndrome. J Clin Invest 39 364-377.
101. W Blunck (1968) Die Beta-ketolischen Cortisol und Corticosteronmetaboliten sowie die 11-oxy-und 11-desoxy-17-ketosteroide im urin von Kindern. Acta Endocrinol 59(Suppl 134), 9-112.
102. OC Green, CJ Migeon and L Wilkins (1960) Urinary steroids in the hypertensive form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 20 929-946.
103. A Glenthoj, MD Nielsen and J Starup (1980) Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency: final diagnosis in adult age in three patients. Acta Endocrinol (Copenh) 93 94-99.
104. M New, R Nemery, D Chow, et al. (1989) The adrenal and hypertension: from cloning to clinic. Ares-Serona Symposium New York: Raven Press
105. M Zachmann, D Tassinari and A Prader (1983) Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab 56 222-229.
106. A Rösler (1992) Classic and nonclassic congenital adrenal hyperplasia among non-Ashkenazi Jews. B Bonne-Tamir, A Adam,(Eds) New perspectives on genetic markers and diseases among the Jewish people Oxford: Oxford University Press 488.
107. T Kawamoto, Y Mitsuuchi, T Ohnishi, et al. (1990) Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. Biochem Biophys Res Commun 173 309-316.
108. KM Curnow, MT Tusie-Luna, L Pascoe, et al. (1991) The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 5 1513-1522.
109. T Ogishima, H Shibata, H Shimada, et al. (1991) Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism. J Biol Chem 266 10731-10734.
110. DW Nebert, M Adesnik, MJ Coon, et al. (1987) The P450 gene superfamily: recommended nomenclature. DNA 6 1-13.
111. PC White, J Dupont, MI New, et al. (1991) A mutation in CYP11B1 (Arg-448-His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 87 1664-1667.
112. KM Curnow, L Slutsker, J Vitek, et al. (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A 90 4552-4556.
113. S Geley, K Kapelari, K Johrer, et al. (1996) CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab 81 2896-2901.
114. W Eberlein and A Bongiovanni (1956) Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J Biol Chem 223 85-94.
115. M Mimouni, H Kaufman, A Roitman, et al. (1985) Hypertension in a neonate with 11 beta-hydroxylase deficiency. Eur J Pediatr 143 231-233.
116. Z Hochberg, J Schechter, et al. (1985) Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Arch J Dis Child 139 771-776.
117. Y Mitsuuchi, K Kawamoto, S Ulick, et al. (1993) Congenitally defective aldosterone biosynthesis in humans: inactivation of the P450c18 gene CYP11B2 due to nucleotide deletion in CMO I deficient patients. Biochem Biophys Res Commun 190 864-869.
118. S Portrat-Doyen, J Tourniaire, O Richard, et al. (1998) Isolated aldosterone synthetase deficiency caused by simultaneous E98D and V386A mutations in the CYP11B2 gene. J Clin Endocrinol Metab 83 4156-4161.
119. BP Hauffa, J Sólyom, E Gláz, et al. (1991) Severe hypoaldosteronism due to corticosterone methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studies. Eur J Pediatr 150 149-153.
120. P Picco, L Garibaldi, M Cotellessa, et al. (1992) Corticosterone methyl oxidase type II deficiency: a cause of failure to thrive and recurrent dehydration in early infancy. Eur J Pediatr 151 170-173.
121. H Globerman, A Rosler, R Theodor, et al. (1988) An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11-hydroxylase. N Engl J Med 319 1193-1197.
122. L Pascoe, KM Curnow, L Slutsker, et al. (1992) Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A 89 4996-5000.
123. MI New and RE Peterson (1967) A new form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 27 300-305.
124. DJ Sutherland, JL Ruse and JC Laidlaw (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. CMAJ 95 1109-1119.
125. SE Oberfield, LS Levine, E Stoner, et al. (1981) Adrenal glomerulosa function in patients with dexamethasone suppressible hyperaldosteronism. J Clin Endocrinol Metab 53 158-164.
126. MI New, SE Oberfield, LS Levine, et al. (1980) Demonstration of autosomal dominant transmission and absence of HLA linkage in dexamethasone suppressible hyperaldosteronism. Lancet 1 550-551.
127. S Ulick and M Chu (1982) Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin Exp Hypertens A 4 1771-1777.
128. C Gomez-Sanchez, M Montgomery, A Ganguly, et al. (1984) Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 59 1022-1024.
129. RP Lifton, RG Dluhy, M Powers, et al. (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355 262-265.
130. L Pascoe, KM Curnow, L Slutsker, et al. (1992) Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A 89 8327-8331.
131. Y Lachance, V Luu-The, C Labrie, et al. (1990) Characterization of human 3β-hydroxysteroid dehydrogenase/D5-D4 isomerase gene and its expression in mammalian cells. J Biol Chem 265 20469-20475.
132. Y Lachance, V Luu-The, H Verreault, et al. (1991) Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity. DNA Cell Biol 10 701-711.
133. E Rhéaume, J Simard, Y Morel, et al. (1992) Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene. Nat Genet 1 239-245.
134. J Simard, E Rheaume, R Sanchez, et al. (1993) Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 7 716-728.
135. A Bongiovanni (1962) Adrenogenital syndrome with deficiency of 3beta-hydroxysteroid dehydrogenase. J Clin Invest 41 2086-2092.
136. AM Bongiovanni (1984) Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase. MI New, LS Levine,(Eds) Adrenal Diseases in Childhood Basel: Karger 72-82.
137. S Pang, LS Levine, E Stoner, et al. (1983) Non-salt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. J Clin Endocrinol Metab 56 808-818.
138. RL Rosenfield, BH Rich, JI Wolfsdorf, et al. (1980) Pubertal presentation of congenital delta 5–3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 51 345-353.
139. P Schram, M Zerah, P Mani, et al. (1992) Nonclassical 3 beta-hydroxysteroid dehydrogenase deficiency: a review of our experience with 25 female patients. Fertil Steril 58 129-136.
140. M Zerah, P Schram and M New (1991) The diagnosis and treatment of nonclassical 3β-HSD deficiency. Endocrinologist 1 75-81.
141. MC Lorence, CJ Corbin, N Kamimura, et al. (1990) Structural analysis of the gene encoding human 3β-hydroxysteroid dehydrogenase/D5,4-isomerase. Mol Endocrinol 4 1850-1855.
142. N Katsumata, A Tanae, T Yasunaga, et al. (1995) A novel missense mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency. Hum Mol Genet 4 745-746.
143. T Tajima, K Fujieda, J Nakae, et al. (1995) Molecular analysis of type II 3β-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3β-hydroxysteroid dehydrogenase deficiency. Hum Mol Genet 4 969-971.
144. Y Morel, F Mebarki, E Rheaume, et al. (1997) 3β-Hydroxysteroid dehydrogenase: Contribution made by the molecular genetics of 3β-hydroxysteroid dehydrogenase deficiency. Steroids 62 176-184.
145. C Lutfallah, W Wang, JI Mason, et al. (2002) Newly proposed hormonal criteria via genotypic proof for type II 3-beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 87 2611-2622.
146. T Yanase, E Simpson and M Waterman (1991) 17 Alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12 91-108.
147. K Miura, K Yasuda, T Yanase, et al. (1996) Mutation of cytochrome P-45017a gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 81 3797-3801.
148. M Zachmann and A Prader (1984) 17,20-Desmolase deficiency. M New, L Levine,(Eds) Adrenal Disease in Childhood Basel: Karger
149. M Zachmann, B Kempken, B Manella, et al. (1992) Conversion from pure 17,20-desmolase- to combined 17,20-desmolase/17 alpha-hydroxylase deficiency with age. Acta Endocrinol (Copenh) 127 97-99.
150. RM Martin, CJ Lin, EMF Costa, et al. (2003) P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88 5739-5746.
151. F Mantero, C Scaroni, CV Pasini, et al. (1980) No linkage between HLA and congenital adrenal hyperplasia due to 17b-hydroxylase deficiency [letter]. N Engl J Med 303 530.
152. ALM Boehmer, AO Brinkmann, LA Sandkuijl, et al. (1999) 17-Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84 4713-4721.
153. D Levran, I Ben-Shlomo, C Pariente, et al. (2003) Familial partial 17,20-desmolase and 17alpha-hydroxylase deficiency presenting as infertility. J Assist Reprod Genet 20 21-28.
154. S Ulick (1976) Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway. J Clin Endocrinol Metab 43 92-96.
155. GT Griffing, TE Wilson, MM Holbrook, et al. (1984) Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome. J Clin Endocrinol Metab 59 1011-1015.
156. JM Wit, HPC van Roermund, W Oostdik, et al. (1988) Heterozygotes for 17α-hydroxylase deficiency can be detected with a short ACTH test. Clin Endocrinol 28 657-664.
157. K Miura, K Yoshinaga, K Goto, et al. (1968) A case of glucocorticoid-responsive hyperaldosteronism. J Clin Endocrinol Metab 28 1807-1815.
158. B Chung, J Picado-Leonard, M Haniu, et al. (1987) Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci U S A 84 407-411.
159. K Matteson, J Picado-Leonard, B Chung, et al. (1986) Assignment of the gene for adrenal P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab 63 789-791.
160. T Imai, T Yanase, M Waterman, et al. (1992) Canadian Mennonites and individuals residing in the Friesland region of The Netherlands share the same molecular basis of 17 alpha-hydroxylase deficiency. Hum Genet 89 95-96.
161. M D’Armiento, G Reda, C Kater, et al. (1983) 17a-Hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family. J Clin Endocrinol Metab 56 697-701.
162. L Williamson, W Arlt, et al. (2006) Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency. Am J Med Genet 140A 1797-1803.
163. CE Flück, T Tajima, AV Pandey, et al. (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36 228-230.
164. W Arlt, EA Walker, N Draper, et al. (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363 2128-2135.
165. C Shackleton, J Marcos, EM Malunowicz, et al. (2004) Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet (Part A) 128A 223-231.
166. A Prader and HP Gurtner (1955) Das Syndrom des Pseudohermaphroditismus masculinus bei kongenitaler Nebennierenden-Hyperplasie ohne Androgenüberproduktion (Adrenaler Pseudohermaphroditismus masculinus). Helv Paediatr Acta 10 397-412.
167. HW Yoo and GH Kim (1998) Molecular and clinical characterization of Korean patients with congenital lipoid adrenal hyperplasia. J Pediatr Endocrinol Metab 11 707-711.
168. HS Bose, S Sato, J Aisenberg, et al. (2000) Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 85 3636-3639.
169. T Tajima, K Fujieda, N Kouda, et al. (2001) Heterozygous mutation in the cholesterol side chain cleavage enzyme (P450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86 3820-3825.
170. N Katsumata, M Ohtake, T Hojo, et al. (2002) Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 87 3808-3813.
171. BY Baker, L Lin, et al. (2006) Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab 91 4781-4785.
172. HS Bose, T Sugawara, JF Strauss III, et al. (1996) The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 335 1870-1878.
173. KM Caron, S-C Soo, WC Wetsel, et al. (1997) Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Nat Acad Sci U S A 94 11540-11545.
174. X Luo, Y Ikeda and KL Parker (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77 481-490.
175. AN Harris and PL Mellon (1998) The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells. Mol Endocrinol 12 714-726.
176. GD Hammer, I Krylova, Y Zhang, et al. (1999) Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 3 521-526.
177. A Tremblay, GB Tremblay, F Labrie, et al. (1999) Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell 3 513-519.
178. W-H Shen, CCD Moore, Y Ikeda, et al. (1994) Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77 651-661.
179. M Nachtigal, Y Hirokawa, HD Enyeart-Van, et al. (1998) Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93 445-454.
180. R Sekido and R Lovell-Badge (2008) Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453 930-934.
181. JC Achermann, M Ito, M Ito, et al. (1999) A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans [letter]. Nat Genet 22 125-126.
182. JC Achermann, G Ozisik, M Ito, et al. (2002) Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87 1829-1833.
183. A Biason-Lauber and EJ Schoenle (2000) Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67 1563-1568.
184. A Biason-Lauber and EJ Schoenle (2000) Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67 1563-1568.
185. ERB McCabe (1996) Sex and the single DAX1: too little is bad, but can we have too much? J Clin Invest 98 881-882.
186. E Zanaria, F Muscatelli, et al. (1994) An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372 635-641.
187. A Swain, E Zanaria, et al. (1996) Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 12 404-409.
188. L Lin, W-X Gu, et al. (2006) Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years’ experience. J Clin Endocrinol Metab 91 3048-3054.
189. L Wilkins, R Lewis, R Klein, et al. (1950) The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull Johns Hopkins Hosp 86 249-252.
190. F Bartter (1977) Adrenogenital syndromes from physiology to chemistry, 1950–1975. P Lee,(Eds) Congenital Adrenal Hyperplasia Baltimore: University Park Press 9-18.
191. MI New (2004) An update of congenital adrenal hyperplasia. Ann N Y Acad Sci 1038 14-43.
192. C Godard, A Riondel and R Veyrat (1968) Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia. Pediatrics 41 883-904.
193. A Simopoulos, J Marshall, C Delea, et al. (1971) Studies on the deficiency of the deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia. J Clin Endocrinol 32 438-443.
194. A Strickland and T Kotchen (1972) A study of the renin-aldosterone system in congenital adrenal hyperplasia. J Pediatr 81 962-969.
195. M Dillon (1975) Plasma renin activity and aldosterone concentrations in children: results in salt-wasting states. Arch Dis Child 50 330.
196. C Edwin, R Lanes and C Migeon (1979) Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia. J Pediatr 95 534.
197. A Rösler, LS Levine, B Schneider, et al. (1977) The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J Clin Endocrinol Metab 45 500-512.
198. U Kuhnle, A Rosler, JA Pareira, et al. (1983) The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency. Acta Endocrinol (Copenh) 102 577-582.
199. J Winter (1980) Current approaches to the treatment of congenital adrenal hyperplasia [editorial]. J Pediatr 97 81-82.
200. S Korth-Schutz, R Virdis, P Saenger, et al. (1978) Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 46 452-458.
201. M Golden, B Lippe and S Kaplan (1978) Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations. Pediatrics 61 867-871.
202. K Döhler (1986) The special case of hormonal imprinting, the neonatal influence of sex. Experientia 42 759-769.
203. K Döhler, J Hancke and S Srivastava (1984) Participation of estrogens in female sexual differentiation of the brain: Neuroanatomical, neuroendocrine, and behavioral evidence. Prog Brain Res 61 99-117.
204. SA Berenbaum (1990) Congenital adrenal hyperplasia: intellectual and psychosexual functioning. CPS Holmes,(Eds) Psychoneuroendocrinology: Brain, Behavioral, and Hormonal Interactions New York: Springer-Verlag 227-260.
205. R Nass and S Baker (1991) Learning disabilities in children with congenital adrenal hyperplasia. J Child Neurol 6 306-312.
206. R Nass, L Heier, T Moshang, et al. (1997) Magnetic resonance imaging in the congenital adrenal hyperplasia population: increased frequency of white-matter abnormalities and temporal lobe atrophy. J Child Neurol 12 181-186.
207. A Nordenstrom, A Servin, G Bohlin, et al. (2002) Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 87 5119-5124.
208. SC Mueller, V Temple, et al. (2008) Early androgen exposure modulates spatial cognition in congenital adrenal hyperplasia (CAH). Psychoneuroendocrinology 33 973-980.
209. DN Long and CJ Wisniewski (2004) Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 17 1367-1373.
210. G Herdt and J Davidson (1988) The Sambia “turnim-man”: sociocultural and clinical aspects of gender formation in male pseudohermaphrodites with 5-alpha-reductase deficiency in Papua New Guinea. Arch Sex Behav 17 33-56.
211. P Price, J Wass, J Griffin, et al. (1984) High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. J Clin Invest 74 1496-1508.
212. J Money, JG Hampson and JL Hampson (1955) Hermaphroditism: recommendations concerning assignment of sex, change of sex, and psychologic management. Bull Johns Hopkins Hosp 96 284-300.
213. J Money and AA Ehrhardt (1972) Differentiation and dimorphism of gender identity from conception to maturity. Man and Woman, Boy and Girl Baltimore: Johns Hopkins University Press
214. AB Dessens, FM Slijper, et al. (2005) Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 34 389-397.
215. S Baker (1981) Psychological management of intersex children. N Josso,(Eds) The Intersex Child Basel: Karger
216. HFL Meyer-Bahlburg (1993) Gender identity development in intersex patients. Child Adolesc Psychiatry Clin North Am 2 501-512.
217. C Nihoul-Fekete (1981) Feminizing genitoplasty in the intersex child. N Josso,(Eds) The Intersex Child Basel: Karger
218. T Jeffcoate, J Fleigner, S Russell, et al. (1965) Diagnosis of the adrenogenital syndrome before birth. Lancet 2 553-555.
219. IR Merkatz, MI New, RE Peterson, et al. (1969) Prenatal diagnosis of adrenogenital syndrome by amniocentesis. J Pediatr 75 977-982.
220. MI New and LS Levine (1973) Congenital adrenal hyperplasia. H Harris, K Hirschhorn,(Eds) Advances in Human Genetics New York: Plenum 251-326.
221. L Levine (1986) Prenatal detection of congenital adrenal hyperplasia. A Milunsky,(Eds) Genetic Disorders and the Fetus New York: Plenum 369-385.
222. S Frasier, I Thorneycroft, B Weiss, et al. (1975) Elevated amniotic fluid concentration of 17 alpha-hydroxyprogesterone in congenital adrenal hyperplasia [letter]. J Pediatr 86 310-312.
223. M Nagamani, P McDonough, J Ellegood, et al. (1978) Maternal and amniotic fluid 17 alpha-hydroxyprogesterone levels during pregnancy: diagnosis of congenital adrenal hyperplasia in utero. Am J Obstet Gynecol 130 791-794.
224. I Hughes and K Laurence (1979) Antenatal diagnosis of congenital adrenal hyperplasia. Lancet 2 7-9.
225. S Pang, LS Levine, LL Cederqvist, et al. (1980) Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses. J Clin Endocrinol Metab 51 223-229.
226. I Hughes and K Laurence (1982) Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by amniotic fluid steroid analysis. Prenat Diagn 2 97-102.
227. S Pang, MS Pollack, M Loo, et al. (1985) Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 61 89-97.
228. S Frasier, B Weiss and R Horton (1974) Amniotic fluid testosterone: implications for the prenatal diagnosis of congenital adrenal hyperplasia. J Pediatr 84 738-741.
229. MS Pollack, D Maurer, LS Levine, et al. (1979) Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet 1 1107-1108.
230. PW Speiser, J Dupont, D Zhu, et al. (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90 584-595.
231. JW Werkmeister, MI New, B Dupont, et al. (1986) Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet 39 461-469.
232. S Collier, PJ Sinnott, PA Dyer, et al. (1989) Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency. EMBO J 8 1393-1402.
233. A Rösler, E Leiberman and A Rosenmann (1979) Prenatal diagnosis of 11beta hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 49 546-551.
234. Z Schumert, A Rosenmann, H Landau, et al. (1980) 11-Deoxycortisol in amniotic fluid: prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Clin Endocrinol 12 257-260.
235. A Rösler, N Weshler, E Leiberman, et al. (1988) 11β-Hydroxylase deficiency congenital adrenal hyperplasia: update of prenatal diagnosis. J Clin Endocrinol Metab 66 830-838.
236. M David and MG Forest (1984) Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 105 799-803.
237. M Evans, G Chrousos, D Mann, et al. (1985) Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia. JAMA 253 1015-1020.
238. Dorr H, Sippell W, Haack D, et al: Pitfalls of prenatal treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Paper presented at the 25th Annual Meeting of the European Society for Paediatric Endocrinology, 1986, Zurich.
239. M Forest, H Betuel and M David (1987) Traitement antenatal de l’hyperplasie congenitale des surrenales par deficit en 21-hydroxylase: Etude multicentrique. Ann Endocrinol 48 31-34.
240. PW Speiser, N Laforgia, K Kato, et al. (1990) First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). J Clin Endocrinol Metab 70 838-848.
241. MG Forest, M David and Y Morel (1993) Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 45 75-82.
242. AB Mercado, RC Wilson, KC Cheng, et al. (1995) Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 80 2014-2020.
243. AD Carlson, JS Obeid, N Kanellopoulou, et al. (1999) Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol 69 19-29.
244. MI New, A Carlson, J Obeid, et al. (2001) Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86 5651-5657.
245. MI New, A Carlson, J Obeid, et al. (2003) Update: prenatal diagnosis for congenital adrenal hyperplasia in 595 pregnancies. Endocrinologist 13 233-239.
246. A Goldman, B Sharpior and M Katsumata (1978) Human foetal palatal corticoid receptors and teratogens for cleft palate. Nature 272 464-466.
247. S Lajic, A Levo, et al. (1997) A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. Hum Genet 99 704-709.
248. T Hirvikoski, A Nordenstrom, et al. (2008) Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol 159 309-316.
249. MG Forest and HG Dörr (2003) Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: retrospective follow-up study of 253 treated pregnancies in 215 families. Endocrinologist 13 252-259.
250. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group (1989) Multicentre randomised clinical trial of chorion villus sampling and amniocentesis: first report. Lancet 333 1-6.